{"DataElement":{"publicId":"13300759","version":"1","preferredName":"Medical History Supplemental Qualifiers Dataset Unfavorable Hodgkin Lymphoma Prognostic Factors Type","preferredDefinition":"The type of prognostic factors of unfavorable Hodgkin lymphoma.","longName":"SUPPMH_QVAL_MHUNFAVORABLEFACT","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"13300664","version":"1","preferredName":"Medical History Supplemental Qualifiers Dataset Unfavorable Hodgkin Lymphoma Prognostic Factors","preferredDefinition":"A dataset containing supplemental information, specifically non-standard variables, to parent records in the medical history domain._A Hodgkin lymphoma with unfavorable prognosis.:The general personal and health characteristics that have a bearing on the course of a disease and its eventual outcome.","longName":"13300663v1.00:2512745v1.00","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"13300663","version":"1","preferredName":"Medical History Supplemental Qualifiers Dataset Unfavorable Hodgkin Lymphoma","preferredDefinition":"A dataset containing supplemental information, specifically non-standard variables, to parent records in the medical history domain._A Hodgkin lymphoma with unfavorable prognosis.","longName":"C147223:C68663","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Medical History Supplemental Qualifiers Dataset","conceptCode":"C147223","definition":"A dataset containing supplemental information, specifically non-standard variables, to parent records in the medical history domain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Unfavorable Hodgkin Lymphoma","conceptCode":"C68663","definition":"A Hodgkin lymphoma with unfavorable prognosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8750F2A-2319-4132-E053-731AD00AF62A","latestVersionIndicator":"Yes","beginDate":"2023-04-03","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-04-03","modifiedBy":"MMADDINENI","dateModified":"2023-04-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2512745","version":"1","preferredName":"Prognostic Factor","preferredDefinition":"The general personal and health characteristics that have a bearing on the course of a disease and its eventual outcome.","longName":"C18959","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prognostic Factor","conceptCode":"C18959","definition":"The general personal and health characteristics that have a bearing on the course of a disease and its eventual outcome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B8A7139-E347-2994-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-21","endDate":null,"createdBy":"UMLLOADER_AGNIS","dateCreated":"2006-08-21","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8750F2A-231A-4132-E053-731AD00AF62A","latestVersionIndicator":"Yes","beginDate":"2023-04-03","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-04-03","modifiedBy":"MMADDINENI","dateModified":"2023-06-07","changeDescription":null,"administrativeNotes":"06/07/2023- Reviewed and released -MM","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"13300666","version":"1","preferredName":"Unfavorable Hodgkin Lymphoma Prognostic Factor Type","preferredDefinition":"A Hodgkin lymphoma with unfavorable prognosis._The general personal and health characteristics that have a bearing on the course of a disease and its eventual outcome._Something distinguishable as an identifiable class based on common qualities.","longName":"13300666v1.00","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Large mediastinal mass","valueDescription":null,"ValueMeaning":{"publicId":"13300687","version":"1","preferredName":"Bulky Mediastinal Mass","longName":"13300687v1.00","preferredDefinition":"When the maximum width of a mass is equal or greater than one-third of the internal transverse diameter of the thorax at the level of T5/6 on a PA CXR. Bulk at an alternate site is defined as any mass measuring 10 cm or more by any imaging study.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bulky Mediastinal Mass","conceptCode":"C178075","definition":"When the maximum width of a mass is equal or greater than one-third of the internal transverse diameter of the thorax at the level of T5/6 on a PA CXR. Bulk at an alternate site is defined as any mass measuring 10 cm or more by any imaging study.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F875BF27-A8F3-6687-E053-731AD00A0E07","latestVersionIndicator":"Yes","beginDate":"2023-04-03","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-04-03","modifiedBy":"KUMMEROA","dateModified":"2023-04-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F875BF27-A8F7-6687-E053-731AD00A0E07","beginDate":"2023-04-03","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-04-03","modifiedBy":"MMADDINENI","dateModified":"2023-04-03","deletedIndicator":"No"},{"value":"B symptoms with ESR greater than 30","valueDescription":null,"ValueMeaning":{"publicId":"13300688","version":"1","preferredName":"B-Symptoms With Erythrocyte Sedimentation Rate Measurement Greater Than Thirty","longName":"13300688v1.00","preferredDefinition":"Features commonly associated with lymphoma, including fever above 38C, drenching night sweats, and weight loss of more than 10% of body mass in the previous 6 months.  B symptoms are signs of a poor prognosis in patients with lymphoma._Used to indicate the presence of something or someone._A quantitative measurement of the distance that red blood cells travel in one hour in a sample of unclotted blood._A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status._A natural number greater than twenty-nine and less than thirty-one and the quantity that it denotes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"B-Symptoms","conceptCode":"C43283","definition":"Features commonly associated with lymphoma, including fever above 38C, drenching night sweats, and weight loss of more than 10% of body mass in the previous 6 months.  B symptoms are signs of a poor prognosis in patients with lymphoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"With","conceptCode":"C62355","definition":"Used to indicate the presence of something or someone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Erythrocyte Sedimentation Rate Measurement","conceptCode":"C74611","definition":"A quantitative measurement of the distance that red blood cells travel in one hour in a sample of unclotted blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Greater Than","conceptCode":"C61584","definition":"A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Thirty","conceptCode":"C105797","definition":"A natural number greater than twenty-nine and less than thirty-one and the quantity that it denotes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F875BF27-A8F4-6687-E053-731AD00A0E07","latestVersionIndicator":"Yes","beginDate":"2023-04-03","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-04-03","modifiedBy":"MMADDINENI","dateModified":"2023-04-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F875BF27-A8F8-6687-E053-731AD00A0E07","beginDate":"2023-04-03","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-04-03","modifiedBy":"MMADDINENI","dateModified":"2023-04-03","deletedIndicator":"No"},{"value":"ESR greater than 50 without B symptoms","valueDescription":null,"ValueMeaning":{"publicId":"13300689","version":"1","preferredName":"Erythrocyte Sedimentation Rate Measurement Greater Than Fifty Without B-Symptoms","longName":"13300689v1.00","preferredDefinition":"A quantitative measurement of the distance that red blood cells travel in one hour in a sample of unclotted blood._A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status._A natural number greater than forty-nine and less than fifty-one and the quantity that it denotes._Used to indicate the absence or lack of something or someone._Features commonly associated with lymphoma, including fever above 38C, drenching night sweats, and weight loss of more than 10% of body mass in the previous 6 months.  B symptoms are signs of a poor prognosis in patients with lymphoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Erythrocyte Sedimentation Rate Measurement","conceptCode":"C74611","definition":"A quantitative measurement of the distance that red blood cells travel in one hour in a sample of unclotted blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Greater Than","conceptCode":"C61584","definition":"A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Fifty","conceptCode":"C105785","definition":"A natural number greater than forty-nine and less than fifty-one and the quantity that it denotes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Without","conceptCode":"C25718","definition":"Used to indicate the absence or lack of something or someone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"B-Symptoms","conceptCode":"C43283","definition":"Features commonly associated with lymphoma, including fever above 38C, drenching night sweats, and weight loss of more than 10% of body mass in the previous 6 months.  B symptoms are signs of a poor prognosis in patients with lymphoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F875BF27-A8F5-6687-E053-731AD00A0E07","latestVersionIndicator":"Yes","beginDate":"2023-04-03","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-04-03","modifiedBy":"MMADDINENI","dateModified":"2023-04-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F875BF27-A8F9-6687-E053-731AD00A0E07","beginDate":"2023-04-03","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-04-03","modifiedBy":"MMADDINENI","dateModified":"2023-04-03","deletedIndicator":"No"},{"value":"age greater than 50 years","valueDescription":null,"ValueMeaning":{"publicId":"13300690","version":"1","preferredName":"Age Greater Than Fifty Year","longName":"13300690v1.00","preferredDefinition":"How long something has existed; elapsed time since birth._A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status._A natural number greater than forty-nine and less than fifty-one and the quantity that it denotes._A period of time that it takes for Earth to make a complete revolution around the sun, approximately 365 days; a specific one year period.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Age","conceptCode":"C25150","definition":"How long something has existed; elapsed time since birth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Greater Than","conceptCode":"C61584","definition":"A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Fifty","conceptCode":"C105785","definition":"A natural number greater than forty-nine and less than fifty-one and the quantity that it denotes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Year","conceptCode":"C29848","definition":"A period of time that it takes for Earth to make a complete revolution around the sun, approximately 365 days; a specific one year period.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F875BF27-A8F6-6687-E053-731AD00A0E07","latestVersionIndicator":"Yes","beginDate":"2023-04-03","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-04-03","modifiedBy":"MMADDINENI","dateModified":"2023-04-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F875BF27-A8FA-6687-E053-731AD00A0E07","beginDate":"2023-04-03","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-04-03","modifiedBy":"MMADDINENI","dateModified":"2023-04-03","deletedIndicator":"No"},{"value":"Greater than 3 nodal sites","valueDescription":null,"ValueMeaning":{"publicId":"13300760","version":"1","preferredName":"Greater Than Three Nodal Site","longName":"13300760v1.00","preferredDefinition":"A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status._A natural number greater than 2 and less than 4 and the quantity that it denotes: the sum of two and one._The anatomic site of a tumor node.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Greater Than","conceptCode":"C61584","definition":"A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Three","conceptCode":"C66834","definition":"A natural number greater than 2 and less than 4 and the quantity that it denotes: the sum of two and one.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Nodal Site","conceptCode":"C177358","definition":"The anatomic site of a tumor node.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F875DE11-CD4F-6A06-E053-731AD00AF436","latestVersionIndicator":"Yes","beginDate":"2023-04-03","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-04-03","modifiedBy":"MMADDINENI","dateModified":"2023-04-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F875DE11-CD50-6A06-E053-731AD00AF436","beginDate":"2023-04-03","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-04-03","modifiedBy":"MMADDINENI","dateModified":"2023-04-03","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435021","version":"1","preferredName":"Diagnostic or Prognostic Factor","preferredDefinition":"Top level term which includes Biological Markers, Risk Factors, and Prognostic Factors.","longName":"C20047","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741C99A-9B70-231B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"13300665","version":"1","preferredName":"Unfavorable Hodgkin Lymphoma Prognostic Factor Type","preferredDefinition":"A Hodgkin lymphoma with unfavorable prognosis._The general personal and health characteristics that have a bearing on the course of a disease and its eventual outcome._Something distinguishable as an identifiable class based on common qualities.","longName":"13300665v1.00","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unfavorable Hodgkin Lymphoma","conceptCode":"C68663","definition":"A Hodgkin lymphoma with unfavorable prognosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Prognostic Factor","conceptCode":"C18959","definition":"The general personal and health characteristics that have a bearing on the course of a disease and its eventual outcome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F875474F-2E3A-486C-E053-731AD00A3380","latestVersionIndicator":"Yes","beginDate":"2023-04-03","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-04-03","modifiedBy":"MMADDINENI","dateModified":"2023-04-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F875474F-2E3B-486C-E053-731AD00A3380","latestVersionIndicator":"Yes","beginDate":"2023-04-03","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-04-03","modifiedBy":"MMADDINENI","dateModified":"2023-06-20","changeDescription":null,"administrativeNotes":"06/20/2023- Released upon review-MM","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"Does patient have one or more of the following factors?","url":null,"context":"COG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F875D11E-DBEA-68C5-E053-731AD00A7382","latestVersionIndicator":"Yes","beginDate":"2023-04-03","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-04-03","modifiedBy":"MMADDINENI","dateModified":"2023-06-01","changeDescription":null,"administrativeNotes":"04/03/2023-Created CDE-CADSR0002244-MM","unresolvedIssues":null,"deletedIndicator":"No"}}